BHRC BLOG
5-Amino-1MQ Dosage Guide: Oral Protocol, Cycling & Fat-Loss Research
BHRC · Peptide & Metabolic Research · 5-Amino-1MQ
5-Amino-1MQ Dosage Guide: Oral Protocol, Cycling & Fat-Loss Research
In the world of metabolic research compounds, 5-Amino-1MQ is the one that keeps showing up in “biohacker fat-loss stack” conversations — and, unusually, it’s an oral capsule, not another injectable. It’s often shelved next to peptides, but technically it isn’t one: it’s a small-molecule NNMT inhibitor with genuinely interesting fat-loss data… in mice and cell cultures. This guide gives you the honest version — how it’s thought to work, the oral dosing and cycling people use, what the research actually shows (and doesn’t), and where it might fit alongside a real, physician-supervised metabolic plan. No hype, no promises.
- What it is: 5-amino-1-methylquinolinium — a small-molecule NNMT inhibitor (not a peptide).
- Route: oral capsule — no injections. BHRC’s is 50 mg.
- Researched for: fat loss, cellular energy (NAD+), and metabolic function.
- Evidence level: promising in mice and adipocytes; no human trials yet.
- Status: investigational; used only under medical supervision.
1 · What Is 5-Amino-1MQ?
5-Amino-1MQ (chemical name 5-amino-1-methylquinolinium) is a small-molecule inhibitor of an enzyme called NNMT — nicotinamide N-methyltransferase. It’s frequently sold and discussed alongside peptide therapies, but it isn’t a peptide (no amino-acid chain); it’s a compact synthetic molecule that happens to be taken as an oral capsule. That oral route is a big part of its appeal — most metabolic research compounds require injections.
The interest is simple to state: NNMT tends to be over-active in obese, metabolically stressed fat tissue, and researchers have asked what happens if you turn it down. That question is what makes 5-Amino-1MQ one of the more talked-about entries in metabolic research.
2 · How Does It Work? (NNMT, NAD+ & Fat Cells)
Here’s the mechanism in plain English. NNMT’s job is to “tag” (methylate) nicotinamide — a form of vitamin B3 — using the body’s universal methyl donor, SAM (S-adenosylmethionine). When NNMT is over-active in fat cells, two things happen that researchers care about:
- It burns through nicotinamide that could otherwise be recycled into NAD+ — the coenzyme your mitochondria rely on for energy.
- It drains SAM and shifts fat-cell metabolism toward storing fat (lipogenesis) rather than burning it.
By inhibiting NNMT, the theory goes, more nicotinamide stays available for NAD+ production, SAM is preserved, and fat cells lean toward burning rather than storing. In lab studies, NNMT inhibition lowered 1-methylnicotinamide, raised intracellular NAD+ and SAM, and suppressed lipogenesis in fat cells. In short: it’s a metabolic “efficiency” play, not an appetite drug.
3 · What the Fat-Loss Research Actually Shows
This is where honesty matters. The excitement around 5-Amino-1MQ is real, but it rests almost entirely on animal and cell-culture studies:
- Diet-induced obese mice: in the landmark study, systemic NNMT inhibitors reduced white-fat mass and body weight and shrank fat cells, lowered cholesterol, and — notably — did not reduce food intake or cause observed side effects. One quinoline-derived inhibitor cut body weight by more than 10% and abdominal fat by over 30% in mice.
- Fat cells (3T3-L1 adipocytes): 5-Amino-1MQ treatment reduced lipid accumulation, increased oxygen consumption, and raised cellular NAD+.
- Later studies: NNMT inhibition combined with diet change further reduced body weight, fat mass, and liver fat, and altered gut-microbiome composition.
4 · Dosage & Oral Protocol
Because there are no human trials, there’s no established clinical dose — the figures below reflect how the compound is commonly supplied and used in research-based protocols, for education only.
| Detail | Commonly referenced |
|---|---|
| Form | Oral capsule (BHRC: 50 mg) |
| Typical daily dose | ~50 mg once daily (some protocols 50–150 mg) |
| Timing | Morning; consistency matters more than clock time |
| With food? | Commonly taken with or without food; follow provider guidance |
| Onset expectations | Metabolic effects are gradual, not overnight |
More is not automatically better. Without human dose-finding trials, chasing higher doses is guesswork with unknown safety trade-offs. A provider-guided, conservative approach is the sane one.
5 · Cycling: On, Off & Why
Most people don’t run 5-Amino-1MQ indefinitely. A common pattern is 8–12 weeks “on,” followed by a break, often paired with the parts that actually have decades of human evidence: a real nutrition plan and resistance training. The rationale for cycling is practical rather than proven — it limits open-ended exposure to a compound without long-term human safety data, and it lets you reassess progress with your provider before continuing.
On (8–12 weeks)
Daily oral dose alongside diet, training, and any prescribed metabolic therapy.
Assess
Review body composition, energy, and labs with your provider — not just the scale.
Off
A planned break before deciding whether another cycle makes sense.
6 · Safety & Regulatory Status
Let’s be clear-eyed. 5-Amino-1MQ is investigational: it is not FDA-approved for weight loss or any consumer use, and products are typically labeled research-use-only. In animal studies it was well tolerated with no observed side effects, but animal safety is not human safety, and there is no long-term human data. That’s exactly why it belongs in a medically supervised setting, where a provider screens your history, monitors labs, and integrates it responsibly — never as a random capsule ordered online.
- Not FDA-approved for weight loss; investigational status.
- No published human trials — human dosing and side-effect profile are unknown.
- Use only under medical supervision, with lab monitoring.
- Avoid if pregnant, breastfeeding, or without a provider’s evaluation.
7 · Where It Fits — Stacking & the Bigger Picture
5-Amino-1MQ is a supporting player, not a replacement for the fundamentals. In a supervised medical weight-loss program, it’s sometimes considered alongside:
- NAD+ therapy and MOTS-c — for the cellular-energy/mitochondrial angle it complements.
- GLP-1 medications (semaglutide/tirzepatide) — the appetite side, which 5-Amino-1MQ doesn’t touch. See our semaglutide program & cost guide.
- Diet & resistance training — the only “stack” with decades of human evidence.
New to this category? Start with what peptides are and our roundup of the best peptides for weight loss.
Book a complimentary consultation with a BHRC provider. We’ll review your goals and labs and build a responsible, physician-supervised metabolic plan.
Book Your Free Consultation →Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of the enzyme NNMT (nicotinamide N-methyltransferase). It’s usually grouped with peptides but isn’t one. It’s taken as an oral capsule and is researched for fat loss, cellular energy (NAD+), and metabolic function. It is investigational and not FDA-approved.
Is 5-Amino-1MQ a peptide?
No. Despite being sold by peptide vendors, it’s a small synthetic molecule, not a chain of amino acids. Its practical difference for users is the oral capsule route — no injections.
How does 5-Amino-1MQ work for fat loss?
It inhibits NNMT, an enzyme that’s often over-active in obese fat tissue. In lab studies, inhibiting NNMT preserved nicotinamide and SAM, raised cellular NAD+, and shifted fat cells away from storing fat (lipogenesis) toward burning it. It does not suppress appetite.
What’s the typical 5-Amino-1MQ dosage?
There’s no established clinical dose because there are no human trials. It’s supplied as an oral capsule (BHRC’s is 50 mg), and commonly referenced protocols use about 50 mg once daily, with some running 50–150 mg. Figures are educational; a provider confirms what’s appropriate for you.
How should I cycle it?
A common pattern is 8–12 weeks on followed by a planned break, paired with nutrition and resistance training. Cycling limits open-ended exposure to a compound without long-term human safety data and creates natural checkpoints to reassess with your provider.
Does 5-Amino-1MQ actually work in humans?
Unproven. The encouraging results are from mice and fat-cell studies — including 10%+ body-weight and 30%+ abdominal-fat reductions in mice. There are no published human clinical trials, so human efficacy and dosing remain unknown.
Is 5-Amino-1MQ safe?
It was well tolerated in animal studies with no observed side effects, but animal safety doesn’t guarantee human safety, and there’s no long-term human data. It should be used only under medical supervision with appropriate screening and lab monitoring, and avoided during pregnancy or breastfeeding.
Is it FDA-approved?
No. 5-Amino-1MQ is investigational and not FDA-approved for weight loss or any consumer use as of 2026. Products are typically labeled research-use-only, which is another reason to use it only with a licensed provider.
Can I stack it with semaglutide or NAD+?
In a supervised program, it’s sometimes considered alongside GLP-1 medications (which handle appetite, something 5-Amino-1MQ doesn’t) and NAD+/MOTS-c for the cellular-energy angle. Any combination should be designed and monitored by your provider.
How do I get 5-Amino-1MQ safely?
Through a physician-supervised program. BHRC offers pharmaceutical-grade peptides and metabolic compounds after a consultation and lab review, so dosing and monitoring are handled properly rather than guessed.
Keep Reading — Metabolic & Peptide Guides
- The Best Peptides for Weight Loss
- Semaglutide Weight-Loss Program & Cost
- What Are Peptides? A Beginner’s Guide
- NAD+ Therapy — Cellular Energy & Longevity
- MOTS-c — the Mitochondrial Peptide
Peptide & Metabolic Therapy Near You — BHRC Locations
5-Amino-1MQ and physician-supervised metabolic programs are available at BHRC studios nationwide, including:
- Peptide & weight-loss therapy in West Hollywood, CA
- Metabolic & peptide therapy in West Los Angeles, CA
- Peptide therapy & medical weight loss in Valencia, CA
- Peptide & metabolic therapy in Westlake Village, CA
- Peptide therapy & weight loss in Summerlin / Las Vegas, NV
- Metabolic & peptide therapy in Paradise Valley / Phoenix, AZ
References & Further Reading
- Neelakantan H, et al. Selective and membrane-permeable small molecule inhibitors of NNMT reverse high-fat-diet-induced obesity in mice. Biochemical Pharmacology (2018). ncbi.nlm.nih.gov
- Neelakantan H, et al. A small molecule inhibitor of NNMT for the treatment of metabolic disorders. ncbi.nlm.nih.gov
- Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome. Frontiers in Pharmacology (2024). frontiersin.org
- Novel tricyclic small-molecule inhibitors of NNMT for the treatment of metabolic disorders. Scientific Reports (2022). nature.com
- Effect of nicotinamide N-methyltransferase on lipid accumulation in 3T3-L1 adipocytes. PMC (2022). ncbi.nlm.nih.gov
- NNMT: at the crossroads between cellular metabolism and epigenetic regulation. PMC. ncbi.nlm.nih.gov
Beverly Hills Rejuvenation Center. This content is for general education and does not create a physician-patient relationship or constitute medical advice. 5-Amino-1MQ is investigational and not FDA-approved for weight loss or any consumer use; it has not been evaluated in published human clinical trials. Any use should occur only under the supervision of a licensed provider after individual evaluation. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Reviewed by the BHRC clinical team; information current as of August 2026.
